MS
Matthew Sykes Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Fortrea Holdings
FTRE
$914M
| $10.07 | $5 |
50%
downside
| Neutral |
14 May ‘25
3 months ago |
|
2
Cytek Biosciences
CTKB
$522M
| $3.93 | $3 |
24%
downside
| Sell |
12 May ‘25
4 months ago |
|
3
10x Genomics
TXG
$1.68B
| $13.50 | $6.50 |
52%
downside
| Sell |
12 May ‘25
4 months ago |
|
4
Bruker
BRKR
$4.73B
| $31.18 | $45 |
44%
upside
| Neutral |
8 May ‘25
4 months ago |
|
5
Myriad Genetics
MYGN
$643M
| $6.97 | $8 |
15%
upside
| Buy |
7 May ‘25
4 months ago |
|
6
Twist Bioscience
TWST
$1.51B
| $25.09 | $48 |
91%
upside
| Buy |
6 May ‘25
4 months ago |
|
7
Sotera Health
SHC
$4.52B
| $15.81 | $17 |
8%
upside
| Buy |
5 May ‘25
4 months ago |
|
8
Icon
ICLR
$13.1B
| $168.94 | $160 |
5%
downside
| Neutral |
2 May ‘25
4 months ago |
|
9
NeoGenomics
NEO
$1.02B
| $7.86 | $10 |
27%
upside
| Buy |
30 Apr ‘25
4 months ago |
|
10
Revvity
RVTY
$10B
| $85.04 | $125 |
47%
upside
| Buy |
29 Apr ‘25
4 months ago |
|
11
Avantor
AVTR
$8.75B
| $12.83 | $14 |
9%
upside
| Neutral |
29 Apr ‘25
4 months ago |
|
12
Danaher
DHR
$139B
| $194.33 | $240 |
24%
upside
| Buy |
23 Apr ‘25
4 months ago |
|
13
CareDx
CDNA
$716M
| $13.45 | $26 |
93%
upside
| Buy |
17 Apr ‘25
4 months ago |
|
14
Charles River Laboratories
CRL
$7.97B
| $157.38 | $170 |
8%
upside
| Neutral |
21 Mar ‘25
5 months ago |
|
15
Guardant Health
GH
$7.41B
| $59.44 | $56 |
6%
downside
| Buy |
21 Feb ‘25
6 months ago |
|
16
GeneDx Holdings
WGS
$3.62B
| $125.97 | $80 |
36%
downside
| Neutral |
19 Feb ‘25
6 months ago |
|
17
Pacific Biosciences
PACB
$393M
| $1.31 | $1.50 |
15%
upside
| Neutral |
18 Feb ‘25
6 months ago |
|
18
Natera
NTRA
$24.2B
| $176.37 | $190 |
8%
upside
| Buy |
28 Jan ‘25
7 months ago |
|
19
Nautilus Biotechnolgy
NAUT
$84.6M
| $0.6700 | $1.75 |
161%
upside
| Sell |
5 Dec ‘24
9 months ago |
|
20
Maravai LifeSciences
MRVI
$385M
| $2.66 | $4.25 |
60%
upside
| Sell |
5 Dec ‘24
9 months ago |
|
21
Veracyte
VCYT
$2.55B
| $31.99 | $37 |
16%
upside
| Neutral |
5 Dec ‘24
9 months ago |
|
22
Exact Sciences
EXAS
$10.5B
| $55.41 | $65 |
17%
upside
| Buy |
6 Nov ‘24
10 months ago |
|
23
IQVIA
IQV
$32.2B
| $189.64 | $250 |
32%
upside
| Buy |
1 Nov ‘24
10 months ago |
|
24
Quanterix
QTRX
$199M
| $4.29 | $24 |
459%
upside
| Buy |
9 Jul ‘24
1 year ago |
|
25
Mettler-Toledo International
MTD
$27.1B
| $1,285.31 | $1,300 |
1%
upside
| Neutral |
9 Jul ‘24
1 year ago |
|